American Association for Cancer Research to Host Congressional Briefing About Progress in Cancer Research
- Deputy Director of the National Cancer Institute, Dr. Douglas Lowy, will address the audience.
- Event will showcase the AACR Cancer Progress Report, which is a call to action to make funding for the National Institutes of Health a national priority.
- A foremost expert in blood cancers will describe progress in multiple myeloma.
WASHINGTON, D.C. — The American Association for Cancer Research will host a congressional briefing to highlight recent progress in cancer research and biomedical science, and call on Congress to avoid automatic cuts that would deal a devastating blow to the National Institutes of Health and National Cancer Institute.
The briefing will take place on Tuesday, Feb. 12, from 12-1:30 p.m. ET, in the Rayburn House Office Building, Room B-339. Reporters who wish to attend can register by contacting Jeremy Moore at firstname.lastname@example.org or (215) 446-7109.
AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), will moderate the following distinguished panel of speakers:
- Sen. Jerry Moran, R-Kan. (Invited)
- Douglas R. Lowy, M.D., deputy director of the National Cancer Institute (NCI)
- Anna D. Barker, Ph.D., professor and director of the Transformative Healthcare Networks and co-director of Complex Adaptive Systems Research at Arizona State University
- Kenneth C. Anderson, M.D., director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute and Kraft Family professor of medicine at Harvard Medical School
- The Honorable M. Robert Carr, multiple myeloma survivor and former U.S. Representative from Michigan
During the briefing, panelists will present key advances in cancer research and cancer care as described in the AACR Cancer Progress Report 2012 and will highlight specific advances since the report in blood cancers like multiple myeloma.
Panelists will also discuss key initiatives at the NCI and the critical importance of funding to save more lives.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.